| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 280/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | Lamotrigine |
| Appearance | White Powder |
| CAS No. | 84057-84-1 |
| MF | C9h7cl2n5 |
| MW | 265.09 |
Lamotrigine is a phenyltriazine antiepileptic drug. It is used to treat epilepsy and as an emotional stabilizer for bipolar disorder. Lamotrigine is the first drug approved by the US Food and Drug Administration (FDA) for the maintenance of type I bipolar disorder treatment since lithium was approved. It has been approved for use in over 30 countries.
Lamotrigine has relatively few side effects and does not require laboratory monitoring. Although it is suitable for epilepsy and bipolar disorder, there is evidence to suggest that lamotrigine may have some clinical efficacy in certain neuropathic pain states.
Lamotrigine is a second-generation antiepileptic drug (AED) used in the United Kingdom and the United States as lamotrigine ® Known for its proprietary brand name of GlaxoSmithKline, Brentford.
It is mainly used for partial epilepsy, especially for refractory partial epilepsy that cannot be controlled by other monotherapy or combination therapy. Its effect is safe and effective. About 50% of patients with seizures, atypical seizures, and myoclonic seizures are under control. It is also suitable as an adjuvant drug for the treatment of Lennox Gastant syndrome in refractory epilepsy, as well as secondary and idiopathic generalized tonic clonic seizures.
){kind=link}